Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature

Fig. 1

Expression of CD56, CK19, HBME-1, Galectin-3 in folicular adenoma and follicular variant of papillary carcinoma. a membranous immunoexpression of CD56 in follicular adenoma; (b): absence of immunoexpression of CK19 in follicular adenoma; (c): absence of immunoexpression of HBME-1 in follicular adenoma; (d): absence of imunoexpression of Galectin-3 in follicular adenoma; (e): loss of immunoexpression of CD56 in follicular variant of papillary thyroid carcinoma; (f): membranous and cytoplasmatic immunoexpression of CK 19 in follicular variant of papillary thyroid carcinoma; (g): membranous and cytoplasmatic immunoexpression of HBME-1 in follicular variant of papillary thyroid carcinoma; (h): cytoplasmatic immunoexpression of Galectin-3 in follicular variant of papillary thyroid carcinoma

Back to article page